To confirm these findings more rigorously, future studies should leverage RNA immunoprecipitation sequencing to identify the specific TE transcripts that increase with aging/AD and bind to ADAR1 in different CNS cell types, which could provide insight into the potential to therapeutically target these events. Here, ADAR is linked to Alzheimer disease.